Search

Search Constraints

You searched for: Author/Creator Massimi, Davide

Search Results

1. A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study. (July 2021)

2. A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach. (31st December 2022)

3. Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital. (July 2020)

4. Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital. (July 2020)

7. Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study. Issue 5 (22nd May 2020)

8. Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study. (June 2021)